Pharmaceuticals and the Internet Drug Regulatory Authorities' Perspective - Joint NLN-WHI Workshop, 24-25 September 2001: Country Experiences: Estonia

Table des matières

	Executive Summary
	Overview of activities by the World Health Organization - Dr Lembit Rägo
	Overview of activities by the Nordic Council on Medicines - Dr Ola Westbye
	Country Experiences
		Sweden: Publication bias of clinical trials - Dr Juliette Säwe
		The Netherlands: Pharmaceuticals and e-commerce - Dr Hans Heuvelmans
		Denmark: Web site of the Institute for Rational Pharmacotherapy - Ms Karin Friis Bach
		Denmark: Danish Medicines Agency web site - Mr Karsten Jørgensen
		South Africa: The South African perspective on medicine regulation - Dr Wilbert Bannenberg
		Tunisia - Dr Amor Toumi
		Estonia - Dr Main Uusküla
		Bulgaria: Bulgarian Drug Agency - Rozalina Asenova Kulaksazova
	The Danish Consumer Council - Ms Margrethe Nielsen
	Swedish Industry Association - Dr Håkan Mandahl
	Introduction to discussion points - Dr Lembit Rägo
	Quality aspects - Dr Ola Westbye
	Pilot study on drug regulatory web sites: Current status and future challenges - Ms Elodie Jambert
	The WHO model web site for drug regulatory authorities - Dr Lembit Rägo, Ms Elodie Jambert, Mr Jorg Hetzke
	Concluding discussion
	Annexes
		Annex 1. List of Participants
		Annex 2. List of DRA web sites
	References
	Back cover

Dr Main Uusküla
Bureau of Drug Information and Pharmacovigilance, State Agency of Medicines, Estonia

The web site for the Estonian State Agency of Medicines was presented (Figure 1). It is in both English and Estonian.

Figure 1: Home page of Estonian DRA (http://www.sam.ee/)